481 Home treatment of children with hypogammaglobulinemia with intravenous gammaglobulin (IVIG)

Autor: AD Kobayashi, RH Kobayashi, HD Och, RL Wedgwood

Publikováno v: Journal of Allergy and Clinical Immunology. 81:288

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::af3b1225d3734133de188bbbb580fb6a
https://doi.org/10.1016/0091-6749(88)90715-4

Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectives.

Autor: Kobayashi RH; Division of Pediatric Immunology and Allergy, School of Medicine, University of California, Los Angeles, CA, USA., Maltese J; Medical Affairs, Octapharma USA, Inc, Paramus, NJ, USA., Litzman J; Department of Clinical Immunology and Allergology, St. Anne's University in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia., Kreuwel H; Medical Affairs, Octapharma USA, Inc, Paramus, NJ, USA., Zekoll T; Medical Affairs, Octapharma AG, Vienna, Austria., Kobayashi AL; Medical Affairs, Midland Pediatrics, Papillion, NE, USA., Gupta S; Division of Basic and Clinical Immunology, University of California, Irvine, CA, USA.

Publikováno v: Immunotherapy [Immunotherapy] 2024 Dec 08, pp. 1-11. Date of Electronic Publication: 2024 Dec 08.

Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency.

Autor: Gupta S; Division of Basic and Clinical Immunology, University of California, Irvine, Irvine, CA, USA., Kobayashi RH; School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Litzman J; Department of Clinical Immunology and Allergology, St. Anne's University in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia., Cherwin L; Scientific and Medical Affairs, Octapharma AG, Paramus, NJ, USA., Hoeller S; Scientific and Medical Affairs, Octapharma AG, Paramus, NJ, USA., Kreuwel H; Scientific and Medical Affairs, Octapharma AG, Paramus, NJ, USA.

Publikováno v: Expert review of clinical immunology [Expert Rev Clin Immunol] 2023 Jan; Vol. 19 (1), pp. 7-17. Date of Electronic Publication: 2022 Nov 15.

Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.

Autor: Kobayashi RH; UCLA School of Medicine, Los Angeles, CA, USA., Litzman J; Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia., Melamed I; IMMUNOe Research Center, Centennial, CO, USA., Mandujano JF; Pediatric Pulmonary Associates of North Texas, Frisco, TX, USA., Kobayashi AL; Midlands Pediatrics, Papillion, NE, USA., Ritchie B; Division of Hematology, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada., Geng B; Divisions of Allergy and Immunology, University of California San Diego, La Jolla, CA, USA., Atkinson TP; Department of Pediatric Allergy, Asthma and Immunology, University of Alabama, Birmingham, AL, USA., Rehman S; Allergy and Asthma Center Inc., Toledo, OH, USA., Höller S; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria., Turpel-Kantor E; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria., Kreuwel H; Octapharma US, Paramus, NJ, USA., Speer JC; Octapharma US, Paramus, NJ, USA., Gupta S; Division of Basic and Clinical Immunology, University of California Irvine, Irvine, CA, USA.

Publikováno v: Clinical and experimental immunology [Clin Exp Immunol] 2022 Dec 15; Vol. 210 (2), pp. 91-103.

An Updated Survey of SCID Outcomes Without Preconditioning Chemotherapy.

Autor: Butte MJ; Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, University of California Los Angeles, Los Angeles, Calif. Electronic address: mbutte@mednet.ucla.edu., Kobayashi RH; Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, University of California Los Angeles, Los Angeles, Calif.

Publikováno v: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2022 Apr; Vol. 10 (4), pp. 1084-1085.